Search Articles
Filter Articles
Found 1,054 articles
Announcing Our New Communications CEO, Margot Hannah
- 29 Sep 2021
- Editor
OPEN Health is pleased to announce the appointment of Margot Hannah as the new Chief Executive Officer of OPEN Health Communications. Since joining OPEN Health in 2011, Margot has provided tremendous leadership and dedication to the company. She has held numerous positions, most recently as President of the Medical Communications Center of Excellence, where she has been instrumental in building a high-performance team by developing and retaining best-in-class talent.
Prof. René Schenkendorf joins Insilico Biotechnology AG Scientific Advisory Board
- 29 Sep 2021
- Editor
Insilico Biotechnology AG has announced that Prof. Dr.-Ing. René Schenkendorf has complemented its Scientific Advisory Board. With this further expansion of the board Insilico will be prepared to face the challenges presented by the high demand for biopharma digitalization.
Delta 4 Announces Dr. Hans Lehrach to Join Scientific Advisory Board
- 29 Sep 2021
- Editor
Delta 4, a digital drug discovery company focusing on the identification of new indications for existing drug compounds, today announced that Dr. Hans Lehrach will join its Scientific Advisory Board. Prof. Lehrach is a distinguished scientist in the area of genomics.
Enara Bio announces the appointment of highly experienced biotech executive Dr. Robert Ang to its Board of Directors
- 29 Sep 2021
- Editor
Enara Bio, a biotechnology company advancing novel T-cell receptor (TCR) directed immunotherapies against unconventional, shared, cancer-specific antigens, announces the appointment of Dr. Robert Ang to the Company’s Board of Directors as an independent non-executive director.
Industry peers recognise and reward Pharmadoctor’s achievements with two more golds at the prestigious PM Society Digital Awards.
- 29 Sep 2021
- Editor
Pharmadoctor, the UK’s leading provider of clinical service packages to community pharmacy was presented with two more industry recognised awards at the prestigious PM Society Digital Awards held on 16th September 2021. A first for any company, Pharmadoctor picked up the overall Market Access award for the second consecutive year; this time for its community pharmacy-based ‘Allergy Test ‘n Treat’ service.
-
How to Keep Track of Your CVs
- 24 Sep 2021
- Lucy Walters
Every CV you send off should be tailored to each role you apply for. If you’re sending out lots of applications, it can be easy to lose track of which version of your CV you sent where - but this is something you should stay on top of.
Top Pharma Events in October 2021
- 23 Sep 2021
- Lucy Walters
9 pharmaceutical events taking place in October 2021, including BioFuture Conference, Pharma 2021, Project Management for Clinical Trials and Advanced Process in Pharma.
LovedBy hires former AXA Health executive as Clinical Director
- 22 Sep 2021
- Editor
LovedBy, a technology and consultancy business that exists to improve the lives of people, their families, and communities, today announces the appointment of Dr Arup Paul as its Clinical Director. Dr Paul, who joins from AXA Health where he was Deputy Chief Medical Officer, will be responsible for galvanising LovedBy’s clinical direction as it moves to become a leading provider of global Gen Z healthcare.
Hemab Appoints Mads Behrndt as Chief Financial Officer
- 22 Sep 2021
- Editor
Hemab ApS (“Hemab”), a biotech company developing next generation therapeutics for serious underserved bleeding and thrombosis disorders, today announces the appointment of Mads Behrndt as Chief Financial Officer.
New NHS clinical leadership to support post-COVID challenges
- 22 Sep 2021
- Editor
The five new clinical leads – covering urgent and emergency care, elective care and long COVID – will provide expert advice to the NHS Medical Director, Professor Stephen Powis, and to the programme teams working to support local NHS teams improve services for patients in these areas.
How to Make Your Life Sciences Recruitment Agency Stand Out
- 22 Sep 2021
- Lucy Walters
In the competitive Life Sciences job market, standing out as a recruitment agency can be tough. In this article, we outline 8 things you can do to make your name known in the industry, and to help you continue to attract the best talent for your clients and develop long-lasting relationships with employers across the Life Sciences field.
Genmab and Seagen Announce FDA Accelerated Approval for TIVDAK™ (tisotumab vedotin-tftv) in Previously Treated Recurrent or Metastatic Cervical Cancer
- 21 Sep 2021
- Editor
Genmab A/S (Nasdaq: GMAB) and Seagen Inc. (Nasdaq: SGEN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to TIVDAKTM (tisotumab vedotin-tftv), the first and only approved antibody-drug conjugate (ADC) for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
New Dupixent® (dupilumab) data in patients as young as 6 years old with moderate-to-severe atopic dermatitis to be presented at WCPD and EADV
- 21 Sep 2021
- Editor
New Dupixent® (dupilumab) analyses in patients as young as 6 years old with moderate-to-severe atopic dermatitis will be presented at the 14th World Congress of Pediatric Dermatology Annual Congress (WCPD) from September 22-25 and the 30th European Academy of Dermatology and Venereology Congress (EADV) from September 29-October 2.
InSilicoTrials and Galileo Research announce their partnership
- 21 Sep 2021
- Editor
Innovation and cutting-edge technology to reduce Research and Development time and costs: InSilicoTrials, a company with broad expertise in Computational Modeling and Simulation, IT and cloud solutions for the healthcare sector, and Galileo Research established a partnership to apply in silico services for drug repurposing activities and provide mutual support in modeling and simulation activities.
Aslan Pharmaceuticals Establishes Scientific Advisory Board Chaired by Distinguished Dermatology Expert Dr. Lawrence Eichenfield
- 21 Sep 2021
- Editor
ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the appointment of Dr Lawrence Eichenfield, MD, FAAD, as chair of its Scientific Advisory Board, comprising experts in dermatology and allergic disease from the United States, Canada, Europe, and Asia. Dr Eric Simpson, MD, MCR, was also appointed as a board member.
Macrogen Europe opens sequencing lab in Maastricht
- 21 Sep 2021
- Editor
Genomic sequencing service provider Macrogen Europe has today announced the opening of a new sequencing facility in Maastricht. The strategic location close to the Netherlands’ southern border, combined with a fast in-house sample pickup service, means that Macrogen Europe can now offer Sanger sequencing results within 24 hours of sample pickup throughout Belgium and the Netherlands.
OM Pharma wins the 2021 Geneva Economy Award
- 21 Sep 2021
- Editor
The award will be presented this evening by the Geneva Chamber of Commerce, Industry and Services (CCIG), the State of Geneva, the Office for the Promotion of Industries and Technologies (OPI) and the Office for the Promotion of Equality and Prevention of Violence (BPEV), during a ceremony at the ‘Bâtiment des Forces Motrices’ in Geneva.
Experts from the fields of Pharmaceuticals and Technology come together to deliver our inaugural PharmaTech Integrates Conference
- 21 Sep 2021
- Editor
Life Science Integrates (LSI) is delighted to announce its inaugural PharmaTech Integrates Conference, to be hosted in partnership with the Medicines Manufacturing Innovation Centre on Thursday 23rd September 2021. The past few years have seen exceptional innovation and growth across both the pharmaceutical industry and the technology sector.
Cellbox Solutions Establishes Subsidiary in the USA
- 21 Sep 2021
- Editor
Cellbox Solutions GmbH, developer of the patented Cellbox technology, has founded their U.S. company and is now selling products directly to the U.S./North American market.
Boehringer Ingelheim and Oxford BioTherapeutics Partnership Advances Second Oncology Drug Candidate into the Clinic
- 21 Sep 2021
- Editor
Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and ADC-based therapies, today announced that it has received another milestone payment from Boehringer Ingelheim (BI) for the progress of a second oncology drug candidate (BI 765049), discovered during the first phase of the partnership, into the clinic.
